GV 2021 Gp, L.P., 10% Owner at Prime Medicine, Inc. (PRME), sold 55,000 shares at $16.92 ($586K) on 2023-06-07, disclosed to the SEC on 2023-06-09.
Scheduled sale ($586k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,000 | $0 | 0.0% |
| 2 | $16.92 | 15,000 | $254K | 43.3% |
| 3 | $16.92 | 15,000 | $254K | 43.3% |
| 4 | $0.00 | 5,000 | $0 | 0.0% |
| 5 | $15.74 | 5,000 | $79K | 13.4% |
| Total | $10.66 avg | 55,000 |
| $586K |
| 100% |
| Filing → |
| PRME | SELL | 2023-06-07 | $1.8M | — | Filing → |
| PRME | SELL | 2023-05-22 | $2.5M | — | Filing → |
| PRME | SELL | 2023-05-10 | $11.9M | — | Filing → |